Page last updated: 2024-10-31

mianserin and Dyslipidemia

mianserin has been researched along with Dyslipidemia in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, HR1
Woo, YS1
Wang, HR1
Shim, IH1
Jun, TY1
Bahk, WM1
Moffatt, A1
Ticehurst, S1

Other Studies

2 other studies available for mianserin and Dyslipidemia

ArticleYear
Does mirtazapine interfere with naturalistic diabetes treatment?
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:5

    Topics: Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol;

2014
Mirtazapine-induced massive dyslipidaemia in an elderly woman.
    The Australian and New Zealand journal of psychiatry, 2013, Volume: 47, Issue:6

    Topics: Aged; Antidepressive Agents, Tricyclic; Dyslipidemias; Female; Humans; Mianserin; Mirtazapine

2013